Based in the ZWT Graz, EVOMEDIS was established as a spinoff from our parent company QRSKIN. The successes and experience accumulated by QRSKIN serve as a solid foundation for the development of an improved wound healing solution for the european market, being EVOSens & EVOCellic, and for its future commercialization.

who we are

our mission

We are a research and development stage life science company with a clear vision: to shift the current paradigm of wound management to wound healing. With our products we aim to address a high unmet need for chronic wound and deep second-degree burn patients. Globally, 11 million patients require hospitalization for their burns, while another 50 million patients suffer from chronic wounds in industrialized countries.


our closely linked most trusted global partners

  • 2020
  • 2021
  • 2022
  • 2023

company history


company history


company history


company history


  • Introduction of a porcine wound healing model (DOI: 10.3390/ biomedicines10061286)
  • Granting of different research funds from the FFG an EU
  • Granting of key patent in Brasil, Canda and India
Rendering Riegler Riewe Architekten

company history


  • EVOMEDIS moved to it’s new offices at the ZWT II in Graz

this is evomedis

The management team of EVOMEDIS has extensive experience in R&D, in and outside of the field of wound care. While the team is currently small, we are planning to grow extensively in the next two years. EVOMEDIS can also count on the knowledge of QRSKIN and long-time partners such as COREMED and the Medical University of Graz.

Dr. Martin Funk
CEO, Founder

Dr. Funk has over 25 years of experience in biotech R&D, and has been the COO of QRSKIN since 2014. He has led or owned several companies since 2011 and has management experience since 1996. In 2020 he took the lead of EVOMEDIS.

ives Bernardelli de mattos
Senior Scientist

Bernardelli de Mattos has been working with Tissue Engineering at the University of Würzburg since 2016. His PhD Thesis was developed with a focus on wound healing process. He has six years of experience working in the wound healing field at QRSKIN GmbH.

supervisory / advisory board

Prof. Dr. L. Kamolz

Read More

Prof. Dr. H. Walles

Read More

Prof. Dr. W. Vanscheidt

Read More

contact us

Lets work together,
for the better!

Dr. Martin Funk, CEO


Get in touch